MODERATOR
:
SPEAKER
(S):
Erwin Scharberg, MD, Director of Immunohematology Laboratory, Institute Transfusion Medicine & Immunohematology
Silvano Wendel, MD, PhD, Medical Director, Hospital Sirio Libanes - Blood Bank
Sandra Nance, MS, MT(ASCP)SBB, Senior Director, IRLs, American Red Cross Blood Services
France Noizat-Pirenne, MD, PhD, Medical Director and Scientific Director, Etablissement Franais du Sang, Ile de France
Rare Donor Program: Impact of Molecular Screening
Ziyan Zhu
Description
The implementation and use of molecular screening methods would be predicted to have a significant impact on donor screening and identification of rare donor units. This session will explore screening approaches currently applied in US, France, Brazil, Germany, and China. The program will highlight population-specific challenges, antibody production, HDFN, and address communication, standardization of testing, and a vision for the future.
LEARNER OUTCOMES:
-
Assess the different antibody specificities and unique challenges in different populations.
-
Explore hemolytic disease of fetus and newborn; prevention, treatment, and challenges.
-
Review the history, ethnic diversity, international relationships and impact of globalization on rare donor programs.
-
Share screening approaches for rare donors and describe the impact of screening with molecular testing methods.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.